RU2007118691A - Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника - Google Patents
Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника Download PDFInfo
- Publication number
- RU2007118691A RU2007118691A RU2007118691/14A RU2007118691A RU2007118691A RU 2007118691 A RU2007118691 A RU 2007118691A RU 2007118691/14 A RU2007118691/14 A RU 2007118691/14A RU 2007118691 A RU2007118691 A RU 2007118691A RU 2007118691 A RU2007118691 A RU 2007118691A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- trifluoromethylphenylamide
- intestine
- cyano
- hydroxy
- Prior art date
Links
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 210000000936 intestine Anatomy 0.000 title 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 5
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010058838 Enterocolitis infectious Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000027139 infectious colitis Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62025504P | 2004-10-19 | 2004-10-19 | |
| US60/620,255 | 2004-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007118691A true RU2007118691A (ru) | 2008-11-27 |
Family
ID=35636963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007118691/14A RU2007118691A (ru) | 2004-10-19 | 2005-10-18 | Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070197643A1 (enExample) |
| EP (1) | EP1804782A1 (enExample) |
| JP (1) | JP2008517059A (enExample) |
| KR (1) | KR20070065888A (enExample) |
| CN (1) | CN101043883A (enExample) |
| AU (1) | AU2005295511A1 (enExample) |
| BR (1) | BRPI0518205A (enExample) |
| CA (1) | CA2584655A1 (enExample) |
| IL (1) | IL182591A0 (enExample) |
| MX (1) | MX2007004265A (enExample) |
| RU (1) | RU2007118691A (enExample) |
| SG (1) | SG142305A1 (enExample) |
| WO (1) | WO2006044741A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1909679B1 (en) | 2005-07-11 | 2013-11-20 | Medtronic Ablation Frontiers LLC | Low power tissue ablation system |
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| EP2100881A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Pyrimidyl- or pyridinylaminobenzoic acid derivatives |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| EP2230232A1 (en) | 2009-03-13 | 2010-09-22 | Almirall, S.A. | Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
| EP2228367A1 (en) | 2009-03-13 | 2010-09-15 | Almirall, S.A. | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| EP2277515A1 (en) * | 2009-07-10 | 2011-01-26 | Sanofi-Aventis | Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis |
| AU2010297357B2 (en) * | 2009-09-18 | 2013-11-07 | Sanofi-Aventis Deutschland Gmbh | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability |
| EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| US8686048B2 (en) | 2010-05-06 | 2014-04-01 | Rhizen Pharmaceuticals Sa | Immunomodulator and anti-inflammatory compounds |
| EP2672963A4 (en) | 2011-02-08 | 2015-06-24 | Childrens Medical Center | METHOD FOR THE TREATMENT OF MELANOMA |
| JOP20190207A1 (ar) * | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19547648A1 (de) * | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
| EP1071658B1 (en) * | 1998-04-17 | 2004-06-16 | Parker Hughes Institute | Btk inhibitors and methods for their identification and use |
| GB0005345D0 (en) * | 2000-03-06 | 2000-04-26 | Mathilda & Terence Kennedy Ins | Methods of treating sepsis septic shock and inflammation |
| NZ528076A (en) * | 2001-03-02 | 2005-09-30 | Medimmune Inc | Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules |
| WO2002080897A1 (en) * | 2001-04-05 | 2002-10-17 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| AU2003258454A1 (en) * | 2002-09-06 | 2004-04-30 | Schebo®Biotech Ag | Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
-
2005
- 2005-10-18 EP EP05812243A patent/EP1804782A1/en not_active Ceased
- 2005-10-18 JP JP2007537944A patent/JP2008517059A/ja not_active Abandoned
- 2005-10-18 CN CNA2005800357982A patent/CN101043883A/zh active Pending
- 2005-10-18 AU AU2005295511A patent/AU2005295511A1/en not_active Abandoned
- 2005-10-18 MX MX2007004265A patent/MX2007004265A/es not_active Application Discontinuation
- 2005-10-18 BR BRPI0518205-0A patent/BRPI0518205A/pt not_active IP Right Cessation
- 2005-10-18 SG SG200802858-1A patent/SG142305A1/en unknown
- 2005-10-18 RU RU2007118691/14A patent/RU2007118691A/ru not_active Application Discontinuation
- 2005-10-18 WO PCT/US2005/037161 patent/WO2006044741A1/en not_active Ceased
- 2005-10-18 KR KR1020077008909A patent/KR20070065888A/ko not_active Withdrawn
- 2005-10-18 CA CA002584655A patent/CA2584655A1/en not_active Abandoned
-
2007
- 2007-03-29 US US11/693,358 patent/US20070197643A1/en not_active Abandoned
- 2007-04-16 IL IL182591A patent/IL182591A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL182591A0 (en) | 2007-09-20 |
| EP1804782A1 (en) | 2007-07-11 |
| MX2007004265A (es) | 2008-03-04 |
| BRPI0518205A (pt) | 2008-11-04 |
| CN101043883A (zh) | 2007-09-26 |
| KR20070065888A (ko) | 2007-06-25 |
| CA2584655A1 (en) | 2006-04-27 |
| AU2005295511A1 (en) | 2006-04-27 |
| US20070197643A1 (en) | 2007-08-23 |
| SG142305A1 (en) | 2008-05-28 |
| WO2006044741A1 (en) | 2006-04-27 |
| JP2008517059A (ja) | 2008-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007118691A (ru) | Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника | |
| RU2013111077A (ru) | Дипептидное пролекарство, его применение и лекарственное средство | |
| RU2009126767A (ru) | Производное 1-фенил-1-тио-d-глюцитола | |
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| RU2012118974A (ru) | Комбинации ингибитора pi3k и ингибитора мек | |
| JP2020507589A5 (enExample) | ||
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| JP2011518833A5 (enExample) | ||
| UA95267C2 (en) | Heteroaryl substituted benzothiazoles | |
| IL181049A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| WO2007149030A8 (en) | Novel heteroaryl substituted benzoxazoles | |
| RU2012124268A (ru) | Бензимидазольные соединения и их применения | |
| EP4327886A3 (en) | Pyrimido- pyridazinone compounds and use thereof | |
| JP2010505865A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| RU2008108516A (ru) | 3,11b-ЦИС-ДИГИДРОТЕТРАБЕНАЗИН ДЛЯ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНОГО ЗАБОЛЕВАНИЯ ИЛИ ВОСПАЛЕНИЯ | |
| RU2012137245A (ru) | Индуктор считывания и терапевтический агент для генетических заболеваний, вызванных мутациями типа нонсенс-мутаций | |
| RU2008152751A (ru) | Соли тримебутина и n-десметилтримебутина | |
| JP2011515406A5 (enExample) | ||
| JP2008517059A5 (enExample) | ||
| RU2010141793A (ru) | Терапевтические замещенные циклопентаны | |
| RU2006141647A (ru) | Производные феноксиалкилкарбоновых кислот при лечении воспалительных заболеваний | |
| JP2011251968A5 (enExample) | ||
| RU2007138582A (ru) | Пероральные дозированные формы производных гемцитабина | |
| RU2011111117A (ru) | Лечение аутоиммунных заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090807 |